636
Participants
Start Date
July 31, 2007
Primary Completion Date
April 30, 2010
Study Completion Date
April 30, 2010
Placebo
"Lyophilized, single dose vials and sterile water for~\> injection; 0.5 mL dose; Vaccination schedule: 0, 6 months"
T-DEN-Post-Transfection F17
Lyophilized, single dose vials and sterile water for injection; 0.5 mL dose at 0 and 6 months
T-DEN-Post-Transfection F19
Lyophilized, single dose vials and sterile water for injection; 0.5 mL dose at 0 and 6 months
San Juan Batista Medical School, Caguas
Private Practice, Carolina
St Luke's Memorial Hospital, Ponce
Private Practice, Rio Piedras
RCMI Clinical Research Center, Rio Piedras
Caparra Internal Medicine Research Center, Río Grande
Torre Medica San Vicente de Paul, San Germán
Clinical Research PR, San Juan
Centro de Neumologia Pediatricia, San Juan
Private Practice, San Juan
Dept Pediatria, Esc. De Medicina, San Juan
Collaborators (1)
GlaxoSmithKline
INDUSTRY
U.S. Army Medical Research and Development Command
FED